ArticleEuropean radiology experimental2025
Electrochemotherapy of spinal metastasis using transpedicular approach: a preclinical safety animal study.
Article in European radiology experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundElectrochemotherapy (ECT) of vertebral metastasis is a new treatment option for metastasis that is not accessible to thermal ablation or radiotherapy. A numerical feasibility study has investigated the transpedicular approach for electrode insertion. We conducted a preclinical study to assess its safety.
methodsHistologic examination of the spinal cord was performed in 12 consecutive pigs treated with ECT at three consecutive levels (T11, T12, and L1) to evaluate any cellular or vascular damage. Pigs of group A (n = 6) had an intraoperative neuromonitoring immediately for 1 h after ECT and then were euthanized. Pain and clinical symptoms were daily evaluated for group B (n = 3) and group C (n = 3) until day-3 and day-30, respectively.
resultsAt gross pathology, no apoptosis, no vascular/thrombosis or hemorrhagic focus was observed in any pig. Motor-evoked potential responses of the lower limbs were transiently lost in response in 5 of the 6 pigs, but complete recovery always occurred within 30 min. Clinical examination (groups B and C) revealed no symptoms during the follow-up. Pigs were all able to walk normally, without weakness or paralysis of the lower extremities. No urinary/fecal retention or incontinence was observed, nor any sign of pain.
conclusionOur results confirm that the insertion of electrodes through the pedicles is safe for the ECT of vertebral metastases. Further studies are needed to evaluate the safety profile of ECT of vertebral metastases invading the cortical and epidural fat, which represents a privileged pathway for the electric field between the electrodes. RELEVANCE STATEMENT: Electrochemotherapy of vertebral metastases should be performed using a transpedicular approach for the insertion of electrodes, without definitive sequelae at the spinal cord level. KEY POINTS: Electrochemotherapy is a new treatment for vertebral metastases not accessible to radiotherapy, but it could result in spinal cord injury related to electrical trauma. In a swine model, the transpedicular approach has demonstrated no definitive sequelae at intraoperative neuromonitoring and during clinical follow-up. Electrochemotherapy should be performed using a transpedicular approach to avoid spinal cord damage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.